Serial Number
99289264
Owner
Beacon Therapeutics LimitedAttorney
John MuellerFiling Date
Jul 18, 2025
EYGEXO Trademark
Serial Number: 99289264 • Registration: 8174773
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Rolling Stock Yard, 2nd Floor
London N79AS
Entity Type: 24
Legal Representation
Correspondence Address
John Mueller BakerHostetler
312 Walnut Street
Suite 3200
Cincinnati, OH 45202
United States
Trademark Details
Filing Date
July 18, 2025
Registration Date
March 17, 2026
Published for Opposition
January 27, 2026
Goods & Services
Medical apparatus and instruments for treating eye diseases and conditions; medical apparatus and instruments used in the treatment of ocular disorders; Medical apparatus and instruments for introducing pharmaceutical preparations into the human body; Medical apparatus and instruments for the injection of pharmaceutical preparations; Medical apparatus and instruments for introducing pharmaceutical preparations into the human body, for use in gene therapy and cell therapy
Pharmaceutical preparations and substances for the treatment of eye diseases and conditions; Pharmaceutical preparations for gene therapy and cell therapy for the treatment of eye diseases and conditions; Pharmaceutical preparations and substances for the treatment of ocular disorders; Biotechnological pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders
Medical treatment services in the field of eye diseases and conditions; Provision of medical information and services; Medical information provided to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders
